Cargando…

The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review

Sarcopenia is a geriatric syndrome characterized by decline of skeletal muscle mass and function. Contributing factors include nutritional, genetic, inflammatory, and endocrinal factors. The reported prevalence of sarcopenia in type 2 diabetes mellitus is high, especially in patients with poor glyce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chen-Ning, Tien, Kai-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368208/ https://www.ncbi.nlm.nih.gov/pubmed/32695832 http://dx.doi.org/10.1155/2020/9368583

Ejemplares similares

Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease
por: Lin, Wei-Ren, et al.
Publicado: (2023)

Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review
por: Popovic, Djordje S., et al.
Publicado: (2021)

Dose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure
por: Sharma, D. C., et al.
Publicado: (2017)

Curcumin as a Therapeutic Agent for Sarcopenia
por: Saud Gany, Siti Liyana, et al.
Publicado: (2023)

Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents
por: Almugadam, Babiker Saad, et al.
Publicado: (2020)

Impact of Sarcopenia on Spinal Spondylosis: A Literature Review
por: Kitsuda, Yuki, et al.
Publicado: (2023)

The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth
por: Feng, Yin-Hsun, et al.
Publicado: (2011)

Honey - A Novel Antidiabetic Agent
por: Erejuwa, Omotayo O., et al.
Publicado: (2012)

Commentary: Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
por: Zhao, Li-Min, et al.
Publicado: (2022)

Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
por: Kan, Chengxia, et al.
Publicado: (2021)

Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes
por: Liu, Juanhong, et al.
Publicado: (2019)

Impact of oral antidiabetic agents on bone metabolism
por: Paul, Thomas V., et al.
Publicado: (2015)

Sarcopenia and Chronic Complications of Type 2 Diabetes Mellitus
por: Purnamasari, Dyah, et al.
Publicado: (2022)

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes
por: Tschöpe, Diethelm, et al.
Publicado: (2013)

Prevalence and Impact of Sarcopenia in Chronic Pancreatitis: A Review of the Literature
por: Kuan, Li Lian, et al.
Publicado: (2020)

The effects of antidiabetic agents on heart failure
por: Wijnen, M., et al.
Publicado: (2021)

Antidiabetic Agents for Treatment of Parkinson’s Disease: A Meta-Analysis
por: Wang, Shu-Yi, et al.
Publicado: (2020)

Comparative Efficacy of Novel Antidiabetic Drugs on Albuminuria Outcomes in Type 2 Diabetes: A Systematic Review
por: Liu, Geng, et al.
Publicado: (2023)

Tissue Factor Expression in Obese Type 2 Diabetic Subjects and Its Regulation by Antidiabetic Agents
por: Wang, Jing, et al.
Publicado: (2015)

Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes
por: Tan, Eleonora, et al.
Publicado: (2015)

Insulin versus an oral antidiabetic agent as add-on therapy in type 2 diabetes after failure of an oral antidiabetic regimen: a meta-analysis
por: Gamble, JM, et al.
Publicado: (2008)

Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors
por: Dąbrowski, Mariusz
Publicado: (2021)

Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
por: Ahn, Chang Ho, et al.
Publicado: (2019)

In the Search of Glycoside-Based Molecules as Antidiabetic Agents
por: Pałasz, Aleksandra, et al.
Publicado: (2019)

The Anti-Inflammatory Effect of Novel Antidiabetic Agents
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review
por: Evans, Marc, et al.
Publicado: (2021)

Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus
por: Cheng, Chih-Ning, et al.
Publicado: (2020)

Efficacy of Various Antidiabetic Agents as Add-On Treatments to Metformin in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
por: Poolsup, Nalinee, et al.
Publicado: (2012)

The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms
por: Massimino, Elena, et al.
Publicado: (2021)

Adherence to Oral Antidiabetic Drugs in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis
por: Piragine, Eugenia, et al.
Publicado: (2023)

Antidiabetic Effects of Physical Activity: How It Helps to Control Type 2 Diabetes
por: Wake, Addisu Dabi
Publicado: (2020)

The Effects of Cardioprotective Antidiabetic Therapy on Microbiota in Patients with Type 2 Diabetes Mellitus—A Systematic Review
por: Bica, Ioana-Cristina, et al.
Publicado: (2023)

Can Antidiabetic Medications Affect Telomere Length in Patients with Type 2 Diabetes? A Mini-Review
por: Qin, Baoding
Publicado: (2023)

Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
por: Mesinovic, Jakub, et al.
Publicado: (2019)

A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors
por: Izzo, Anna, et al.
Publicado: (2021)

Relationship Between Body Mass Index, Antidiabetic Agents, and Midterm Mortality in Patients With Both Type 2 Diabetes Mellitus and Acute Coronary Syndrome
por: Jong, Chien‐Boon, et al.
Publicado: (2019)

Economic Impact of Antidiabetic Medications and Glycemic Control on Managed Care Organizations: A Review of the Literature
por: Stephens, Jennifer M., et al.
Publicado: (2006)

Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents
por: Philis-Tsimikas, A, et al.
Publicado: (2013)

Exenatide: A New Promising Antidiabetic Agent
por: Chakraborti, C. K.
Publicado: (2010)

Role of red grape polyphenols as antidiabetic agents
por: Pandey, Kanti Bhooshan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2h27pg28mq07tt8t5tidn0d0ar